On disclosing Alzheimer’s disease: A need of empathy

Abstract

The disclosure of an Alzheimer’s disease (AD) diagnosis is not always carried out following recognized bioethical principles. Inappropriate disclosing attitudes may induce unfortunate psychological impacts on the patients’ well-being, depriving them of an emotionally balanced adjustment to the condition. We present and discuss some examples of such inappropriate professional behavior, contradicting traditional medical teaching that “there are no diseases but patients.” We emphasize patient singularity and the need for a caring and empathy-driven approach to diagnostic disclosure. We underline the need to avoid emotionally charged terms at the time of disclosure and to provide cognitive, physical, and social interaction guidelines as prevention and containment strategies. We call for a revised approach on the appropriate disclosure of an AD diagnosis.

Keywords

Alzheimer’s disease / Diagnostic disclosure / Bioethics

Funding

None.

Conflict of interest

The authors declare they have no competing interests.

References

[1] Mo M, Zacarias-Pons L, Hoang MT, et al. Psychiatric disorders before and after dementia diagnosis. JAMA Netw Open 2023; 6(10):e2338080. doi: 10.1001/jamanetworkopen.2023.3808

[2] Labos E, Fustinoni O. Comunicación del diagnóstico de enfermedad de Alzheimer: Reflexiones bioéticas Delivering the diagnosis of Alzheimer’s disease: Bioethical considerations. Vertex. 2022; 33(157):56-61. doi: 10.53680/vertex.v33i157.267

[3] Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry. 2012; 69:493-498. doi: 10.1001/archgenpsychiatry.2011.1481

[4] Rasmussen H, Rosness TA, Bosnes O, Salvesen Ø, Knutli M, Stordal E. Anxiety and depression as risk factors in frontotemporal dementia and Alzheimer’s disease: The HUNT study. Dement Geriatr Cogn Dis Extra. 2018;8:414-425. doi: 10.1159/000493973

[5] Lecouturier J, Bamford C, Hughes JC, et al. Appropriate disclosure of a diagnosis of dementia: Identifying the key behaviours of “best practice”. BMC Health Serv Res. 2008;8:95. doi: 10.1186/1472-6963-8-95

[6] van Wijngaarden E, Broekhuis G, Leussen C, Kamper A, The AM. The diagnostic disclosure of dementia: An ethnographic exploration. Tijdschr Gerontol Geriatr. 2017;48:169-176. doi: 10.1007/s12439-017-0222-8

[7] Garrett MD. Social Dementia: The Role of Memory. USA: Kindle; 2021.

[8] Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50 percent in nonagenarians. Arch Neurol. 2000; 57:713-719. doi: 10.1001/archneur.57.5.713

[9] Jack CR Jr., Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement. 2024; 20:5143-5169. doi: 10.1002/alz.13859

[10] Snowdon DA, Nun Study. Healthy aging and dementia: Findings from the Nun Study. Ann Intern Med. 2003;139:450-454. doi: 10.7326/0003-481

[11] Garrett MD. Multiple causes of dementia as engineered senescence. Eur J Med Health. 2020;2:227.

[12] Öksüz N, Ghouri R, Taşdelen D, Uludüz D, Özge A. Mild cognitive impairment progression and Alzheimer’s disease risk: A comprehensive analysis of 3553 cases over 203 months. J Clin Med. 2024;13:518. doi: 10.3390/jcm13020518

[13] Jack CR Jr., Bennett DA, Blennow K, et al. NIA-AA research framework: Toward a biological definition of Alzheimer’s disease Alzheimers Dement. 2018; 14:535-562. doi: 10.1016/j.jalz.2018.02.018

[14] Liss JL, Seleri Assunção S, Cummings J, et al. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: A review and synthesis. J Intern Med. 2021; 290:310-334. doi: 10.1111/joim.13244

[15] Labos E, Cavagna M, Pagotto V, Schapira M. Seguimiento longitudinal de pacientes con queja cognitiva: Características y perfiles de progresión. Vertex Rev Arg Psiquiatr. 2021;32:45-54.

[16] Carapelle E, Mundi C, Cassano T, Avolio C. Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease. Int J Mol Sci. 2020;21:6279. doi: 10.3390/ijms21176279

[17] Fisk JD, Beattie BL, Donnelly M, Byszewski A, Molnar FJ. Disclosure of the diagnosis of dementia. Alzheimers Dement. 2007; 3:404-410. doi: 10.1016/j.jalz.2007.07.008

[18] Merckelbach H, Jelicic M, Jonker C. Planting a misdiagnosis of Alzheimer’s disease in a person’s mind. Acta Neuropsychiatr. 2012; 24:60-62. doi: 10.1111/j.1601-5215.2011.00586.x

[19] Nelson ME, Jester DJ, Petkus AJ, Andel R. Cognitive reserve, Alzheimer’s neuropathology, and risk of dementia: A systematic review and meta-analysis. Neuropsychol Rev. 2021;31:233-250. doi: 10.1007/s11065-021-09478-4

[20] Carapelle E, Mundi C, Cassano T, Avolio C. Interaction between cognitive reserve and biomarkers in Alzheimer disease. Int J Mol Sci. 2020;21:6279. doi: 10.3390/ijms21176279

[21] Soldan A, Pettigrew C, Albert M. Cognitive reserve from the perspective of preclinical Alzheimer disease: 2020 update. Clin Geriatr Med. 2020; 36:247-263. doi: 10.1016/j.cger.2019.11.006

[22] Robles MJ, Cucurella E, Informing of the diagnosis in dementia. Spanish J Geriatr Gerontol. 2011; 46:163-169. doi: 10.1016/j.regg.2011.01.008

[23] Beauchamp TL, Childress JF. Principles of Biomedical Ethics. London: Oxford University Press; 1979.

[24] McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001; 58:1803-1809. doi: 10.1001/archneur.58.11.1803

[25] Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456-2477. doi: 10.1093/brain/awr179

[26] Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol. 2007;114:5-22. doi: 10.1007/s00401-007-0237-2